115 results on '"Sugden PH"'
Search Results
2. ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE SUBFAMILIES BY OXIDATIVE STRESS IN THE PERFUSED RAT HEART
- Author
-
Sugden, PH, Fuller, SJ, and Clerk, A
- Published
- 1997
3. MITOGEN-ACTIVATED PROTEIN KINASES ARE ACTIVATED BY OXIDATIVE STRESS AND CYTOKINES IN NEONATAL RAT VENTRICULAR MYOCYTES
- Author
-
Clerk, A and Sugden, PH
- Published
- 1997
4. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.
- Author
-
Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF, Sugden PH, and Balligand JL
- Published
- 2011
5. No improvement in running?
- Author
-
Sugden Ph
- Subjects
Multidisciplinary - Published
- 1992
6. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3‘:5‘-monophosphate-dependent protein kinase
- Author
-
Thomas M. Lincoln, Jackie D. Corbin, David A. Flockhart, West L, McCarthy D, and Sugden Ph
- Subjects
Adenosine 3 5 monophosphate ,Biochemistry ,Chemistry ,Protein subunit ,Cell Biology ,Mitogen-activated protein kinase kinase ,Protein kinase A ,Mode of action ,Molecular Biology - Published
- 1978
7. P95 Effects of dabrafenib and trametinib, cancer therapies that target BRaf and MEK, on cardiac signalling.
- Author
-
Clerk, A, Connell, L, Pipe, M, Fuller, SJ, and Sugden, PH
- Subjects
OXIMES ,CELLULAR signal transduction ,PYRIDONE ,DRUG efficacy ,PROTEIN kinases ,HEART cells ,CARDIAC hypertrophy - Abstract
Background: The extracellular signal-regulated kinase (ERK1/2) cascade is implicated in cardioprotection and cardiac hypertrophy. Enhanced ERK1/2 signalling is associated with cancer, particularly in melanoma in which ~50% of cancers result from mutations of the upstream kinase BRaf that signals through MEK to ERK1/2. Inhibitors of BRaf (e.g. dabrafenib, DAB) and/or MEK (trametinib, TRAM) are in clinical use as cancer therapies. Early studies failed to identify BRaf in the heart and, whilst BRaf and MEK inhibitors are known to affect cardiac function, their molecular effects remain to be established. Materials and methods. Expression of BRaf was assessed in neonatal rat cardiomyocytes and adult rat hearts by immunoblotting. BRaf activities were measured following immunoprecipitation. Adult rat hearts were perfused in the Langendorff mode under control conditions, with DAB or TRAM alone, with fibroblast growth factor (FGF) or with FGF in the presence of DAB or TRAM. Signalling through the ERK1/2 cascade and potential off-target effects on the cytoprotective Akt pathway were assessed by immunoblotting. Results and discussion. BRaf protein was detected in extracts from adult rat hearts or cardiomyocytes as a doublet of ~90 kDa (predicted 89 kDa). Activity assays confirmed that BRaf has high basal activity that was further increased by peptide growth factors. Perfusion of rat hearts with DAB inhibited baseline phosphorylation (i.e. activation) of MEK and ERK1/2, whilst TRAM inhibited baseline activation of ERK1/2. These data suggest that BRaf activity is required for basal ERK1/2 activation in the heart. Both inhibitors prevented activation of ERK1/2 and downstream kinases (p90 RSK, p70 S6K) by FGF further indicating that growth factor signalling is mediated by BRaf in the heart. Interestingly, whilst DAB inhibited basal Akt phosphorylation, TRAM enhanced Akt signalling in control and FGF-perfused hearts. Conclusions. BRaf is expressed in cardiomyocytes and adult hearts at significant levels, has high basal activity and is activated by peptide growth factors. BRaf and MEK inhibitors in use for cancer therapy suppress basal and growth factor induced activation of ERK1/2 signalling suggesting that they are likely to have cardiotoxic effects. However, potentially damaging inhibition of ERK1/2 signalling by TRAM may be mitigated in part by enhanced cytoprotection via Akt if this pathway is not compromised. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
8. The insulin receptor family in the heart: new light on old insights.
- Author
-
Clerk A and Sugden PH
- Subjects
- Insulin metabolism, Myocytes, Cardiac metabolism, Phosphorylation, Signal Transduction, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Receptor, Insulin genetics, Receptor, Insulin metabolism
- Abstract
Insulin was discovered over 100 years ago. Whilst the first half century defined many of the physiological effects of insulin, the second emphasised the mechanisms by which it elicits these effects, implicating a vast array of G proteins and their regulators, lipid and protein kinases and counteracting phosphatases, and more. Potential growth-promoting and protective effects of insulin on the heart emerged from studies of carbohydrate metabolism in the 1960s, but the insulin receptors (and the related receptor for insulin-like growth factors 1 and 2) were not defined until the 1980s. A related third receptor, the insulin receptor-related receptor remained an orphan receptor for many years until it was identified as an alkali-sensor. The mechanisms by which these receptors and the plethora of downstream signalling molecules confer cardioprotection remain elusive. Here, we review important aspects of the effects of the three insulin receptor family members in the heart. Metabolic studies are set in the context of what is now known of insulin receptor family signalling and the role of protein kinase B (PKB or Akt), and the relationship between this and cardiomyocyte survival versus death is discussed. PKB/Akt phosphorylates numerous substrates with potential for cardioprotection in the contractile cardiomyocytes and cardiac non-myocytes. Our overall conclusion is that the effects of insulin on glucose metabolism that were initially identified remain highly pertinent in managing cardiomyocyte energetics and preservation of function. This alone provides a high level of cardioprotection in the face of pathophysiological stressors such as ischaemia and myocardial infarction., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
9. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
- Author
-
Meijles DN, Cull JJ, Markou T, Cooper STE, Haines ZHR, Fuller SJ, O'Gara P, Sheppard MN, Harding SE, Sugden PH, and Clerk A
- Subjects
- Animals, Benzamides pharmacology, Heart drug effects, Hydrogen Peroxide pharmacology, Imidazoles pharmacology, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Oxidation-Reduction, Oxidative Stress drug effects, Protein Kinase Inhibitors pharmacology, Pyridines pharmacology, Rats, Reactive Oxygen Species metabolism, Signal Transduction drug effects, Signal Transduction physiology, Ventricular Remodeling drug effects, Hypertension metabolism, MAP Kinase Kinase Kinase 5 metabolism, Myocardium metabolism, Ventricular Remodeling physiology, p38 Mitogen-Activated Protein Kinases metabolism
- Abstract
Systemic hypertension increases cardiac workload causing cardiomyocyte hypertrophy and increased cardiac fibrosis. An underlying feature is increased production of reactive oxygen species. Redox-sensitive ASK1 (apoptosis signal-regulating kinase 1) activates stress-regulated protein kinases (p38-MAPK [mitogen-activated protein kinases] and JNKs [c-Jun N-terminal kinases]) and promotes fibrosis in various tissues. Here, we determined the specificity of ASK1 signaling in the heart, with the hypothesis that ASK1 inhibitors may be used to manage fibrosis in hypertensive heart disease. Using immunoblotting, we established that moderate levels of H
2 O2 activate ASK1 in neonatal rat cardiomyocytes and perfused rat hearts. ASK1 was activated during ischemia in adult rat hearts, but not on reperfusion, consistent with activation by moderate (not high) reactive oxygen species levels. In contrast, IL (interleukin)-1β activated an alternative kinase, TAK1 (transforming growth factor-activated kinase 1). ASK1 was not activated by IL1β in cardiomyocytes and activation in perfused hearts was due to increased reactive oxygen species. Selonsertib (ASK1 inhibitor) prevented activation of p38-MAPKs (but not JNKs) by oxidative stresses in cultured cardiomyocytes and perfused hearts. In vivo (C57Bl/6J mice with osmotic minipumps for drug delivery), selonsertib (4 mg/[kg·d]) alone did not affect cardiac function/dimensions (assessed by echocardiography). However, it suppressed hypertension-induced cardiac hypertrophy resulting from angiotensin II (0.8 mg/[kg·d], 7d), with inhibition of Nppa/Nppb mRNA upregulation, reduced cardiomyocyte hypertrophy and, notably, significant reductions in interstitial and perivascular fibrosis. Our data identify a specific reactive oxygen species→ASK1→p38-MAPK pathway in the heart and establish that ASK1 inhibitors protect the heart from hypertension-induced cardiac remodeling. Thus, targeting the ASK1→p38-MAPK nexus has potential therapeutic viability as a treatment for hypertensive heart disease.- Published
- 2020
- Full Text
- View/download PDF
10. Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts.
- Author
-
Fuller SJ, Osborne SA, Leonard SJ, Hardyman MA, Vaniotis G, Allen BG, Sugden PH, and Clerk A
- Subjects
- Animals, Female, Gene Expression Profiling, Humans, Proteomics, RNA, Messenger analysis, Rats, Rats, Sprague-Dawley, Heart Failure enzymology, Myocytes, Cardiac enzymology, Protein Kinases genetics
- Abstract
Aims: Protein kinases are potential therapeutic targets for heart failure, but most studies of cardiac protein kinases derive from other systems, an approach that fails to account for specific kinases expressed in the heart and the contractile cardiomyocytes. We aimed to define the cardiomyocyte kinome (i.e. the protein kinases expressed in cardiomyocytes) and identify kinases with altered expression in human failing hearts., Methods and Results: Expression profiling (Affymetrix microarrays) detected >400 protein kinase mRNAs in rat neonatal ventricular myocytes (NVMs) and/or adult ventricular myocytes (AVMs), 32 and 93 of which were significantly up-regulated or down-regulated (greater than two-fold), respectively, in AVMs. Data for AGC family members were validated by qPCR. Proteomics analysis identified >180 cardiomyocyte protein kinases, with high relative expression of mitogen-activated protein kinase cascades and other known cardiomyocyte kinases (e.g. CAMKs, cAMP-dependent protein kinase). Other kinases are poorly investigated (e.g. Slk, Stk24, Oxsr1). Expression of Akt1/2/3, BRaf, ERK1/2, Map2k1, Map3k8, Map4k4, MST1/3, p38-MAPK, PKCδ, Pkn2, Ripk1/2, Tnni3k, and Zak was confirmed by immunoblotting. Relative to total protein, Map3k8 and Tnni3k were up-regulated in AVMs vs. NVMs. Microarray data for human hearts demonstrated variation in kinome expression that may influence responses to kinase inhibitor therapies. Furthermore, some kinases were up-regulated (e.g. NRK, JAK2, STK38L) or down-regulated (e.g. MAP2K1, IRAK1, STK40) in human failing hearts., Conclusion: This characterization of the spectrum of kinases expressed in cardiomyocytes and the heart (cardiomyocyte and cardiac kinomes) identified novel kinases, some of which are differentially expressed in failing human hearts and could serve as potential therapeutic targets., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
11. The early transcriptomic response to interleukin 1β and interleukin 33 in rat neonatal cardiomyocytes.
- Author
-
Barrett OP, Yndestad A, Marshall AK, Sugden PH, and Clerk A
- Subjects
- Animals, Animals, Newborn, Gene Expression Regulation drug effects, Interleukin-33, Myocytes, Cardiac drug effects, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Transcriptome drug effects, Interleukin-1beta pharmacology, Interleukins pharmacology, Myocytes, Cardiac metabolism, Transcriptome genetics
- Abstract
In the heart, inflammatory cytokines including interleukin (IL) 1β are implicated in regulating adaptive and maladaptive changes, whereas IL33 negatively regulates cardiomyocyte hypertrophy and promotes cardioprotection. These agonists signal through a common co-receptor but, in cardiomyocytes, IL1β more potently activates mitogen-activated protein kinases and NFκB, pathways that regulate gene expression. We compared the effects of external application of IL1β and IL33 on the cardiomyocyte transcriptome. Neonatal rat cardiomyocytes were exposed to IL1β or IL33 (0.5, 1 or 2h). Transcriptomic profiles were determined using Affymetrix rat genome 230 2.0 microarrays and data were validated by quantitative PCR. IL1β induced significant changes in more RNAs than IL33 and, generally, to a greater degree. It also had a significantly greater effect in downregulating mRNAs and in regulating mRNAs associated with selected pathways. IL33 had a greater effect on a small, select group of specific transcripts. Thus, differences in intensity of intracellular signals can deliver qualitatively different responses. Quantitatively different responses in production of receptor agonists and transcription factors may contribute to qualitative differences at later times resulting in different phenotypic cellular responses., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
12. MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.
- Author
-
Zhou Y, Adolfs Y, Pijnappel WW, Fuller SJ, Van der Schors RC, Li KW, Sugden PH, Smit AB, Hergovich A, and Pasterkamp RJ
- Subjects
- Adaptor Proteins, Signal Transducing, Animals, Base Sequence, Blotting, Western, COS Cells, Chlorocebus aethiops, Cytoskeletal Proteins genetics, Cytoskeletal Proteins metabolism, HEK293 Cells, Humans, Immunoprecipitation, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, L Cells, LIM Domain Proteins, Mice, Mice, Knockout, Microfilament Proteins, Microtubule-Associated Proteins genetics, Mixed Function Oxygenases genetics, Phosphorylation, Protein Binding, Protein Serine-Threonine Kinases genetics, RNA Interference, Apoptosis, Microtubule-Associated Proteins metabolism, Mixed Function Oxygenases metabolism, Protein Serine-Threonine Kinases metabolism, Signal Transduction
- Abstract
MICALs (molecules interacting with CasL) are atypical multidomain flavoenzymes with diverse cellular functions. The molecular pathways employed by MICAL proteins to exert their cellular effects remain largely uncharacterized. Via an unbiased proteomics approach, we identify MICAL-1 as a binding partner of NDR (nuclear Dbf2-related) kinases. NDR1/2 kinases are known to mediate apoptosis downstream of the mammalian Ste-20-like kinase MST1, and ablation of NDR1 in mice predisposes the mice to cancer as a result of compromised apoptosis. MST1 phosphorylates NDR1/2 kinases at their hydrophobic motif, thereby facilitating full NDR kinase activity and function. However, if and how this key phosphorylation event is regulated are unknown. Here we show that MICAL-1 interacts with the hydrophobic motif of NDR1/2 and that overexpression or knockdown of MICAL-1 reduces or augments NDR kinase activation or activity, respectively. Surprisingly, MICAL-1 is a phosphoprotein but not an NDR or MST1 substrate. Rather, MICAL-1 competes with MST1 for NDR binding and thereby antagonizes MST1-induced NDR activation. In line with this inhibitory effect, overexpression or knockdown of MICAL-1 inhibits or enhances, respectively, NDR-dependent proapoptotic signaling induced by extrinsic stimuli. Our findings unveil a previously unknown biological role for MICAL-1 in apoptosis and define a novel negative regulatory mechanism of MST-NDR signaling.
- Published
- 2011
- Full Text
- View/download PDF
13. Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction.
- Author
-
Korf-Klingebiel M, Kempf T, Schlüter KD, Willenbockel C, Brod T, Heineke J, Schmidt VJ, Jantzen F, Brandes RP, Sugden PH, Drexler H, Molkentin JD, and Wollert KC
- Subjects
- Animals, Bone Morphogenetic Protein 6 genetics, Bone Morphogenetic Protein 6 metabolism, Fibroblast Growth Factor 9 administration & dosage, Fibroblast Growth Factor 9 genetics, Gene Expression drug effects, Heart, Heart Failure mortality, Hypertrophy, Left Ventricular chemically induced, Mice, Mice, Transgenic, Neovascularization, Pathologic chemically induced, Phosphorylation, Rats, Tetracycline pharmacology, Fibroblast Growth Factor 9 pharmacology, Heart Failure prevention & control, Myocardial Infarction complications
- Abstract
Background: Fibroblast growth factor 9 (FGF9) is secreted from bone marrow cells, which have been shown to improve systolic function after myocardial infarction (MI) in a clinical trial. FGF9 promotes cardiac vascularization during embryonic development but is only weakly expressed in the adult heart., Methods and Results: We used a tetracycline-responsive binary transgene system based on the α-myosin heavy chain promoter to test whether conditional expression of FGF9 in the adult myocardium supports adaptation after MI. In sham-operated mice, transgenic FGF9 stimulated left ventricular hypertrophy with microvessel expansion and preserved systolic and diastolic function. After coronary artery ligation, transgenic FGF9 enhanced hypertrophy of the noninfarcted left ventricular myocardium with increased microvessel density, reduced interstitial fibrosis, attenuated fetal gene expression, and improved systolic function. Heart failure mortality after MI was markedly reduced by transgenic FGF9, whereas rupture rates were not affected. Adenoviral FGF9 gene transfer after MI similarly promoted left ventricular hypertrophy with improved systolic function and reduced heart failure mortality. Mechanistically, FGF9 stimulated proliferation and network formation of endothelial cells but induced no direct hypertrophic effects in neonatal or adult rat cardiomyocytes in vitro. FGF9-stimulated endothelial cell supernatants, however, induced cardiomyocyte hypertrophy via paracrine release of bone morphogenetic protein 6. In accord with this observation, expression of bone morphogenetic protein 6 and phosphorylation of its downstream targets SMAD1/5 were increased in the myocardium of FGF9 transgenic mice., Conclusions: Conditional expression of FGF9 promotes myocardial vascularization and hypertrophy with enhanced systolic function and reduced heart failure mortality after MI. These observations suggest a previously unrecognized therapeutic potential for FGF9 after MI.
- Published
- 2011
- Full Text
- View/download PDF
14. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
- Author
-
Eschenhagen T, Force T, Ewer MS, de Keulenaer GW, Suter TM, Anker SD, Avkiran M, de Azambuja E, Balligand JL, Brutsaert DL, Condorelli G, Hansen A, Heymans S, Hill JA, Hirsch E, Hilfiker-Kleiner D, Janssens S, de Jong S, Neubauer G, Pieske B, Ponikowski P, Pirmohamed M, Rauchhaus M, Sawyer D, Sugden PH, Wojta J, Zannad F, and Shah AM
- Subjects
- Anthracyclines adverse effects, Anthracyclines therapeutic use, Antibodies, Monoclonal adverse effects, Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal, Humanized, Antineoplastic Agents therapeutic use, Cardiotoxins, Education, ErbB Receptors drug effects, Europe, Humans, Neoplasms drug therapy, Risk Factors, Sirolimus antagonists & inhibitors, Trastuzumab, Antineoplastic Agents adverse effects, Cardiology standards, Cardiovascular System drug effects, Heart Failure chemically induced, Practice Guidelines as Topic
- Abstract
The reductions in mortality and morbidity being achieved among cancer patients with current therapies represent a major achievement. However, given their mechanisms of action, many anti-cancer agents may have significant potential for cardiovascular side effects, including the induction of heart failure. The magnitude of this problem remains unclear and is not readily apparent from current clinical trials of emerging targeted agents, which generally under-represent older patients and those with significant co-morbidities. The risk of adverse events may also increase when novel agents, which frequently modulate survival pathways, are used in combination with each other or with other conventional cytotoxic chemotherapeutics. The extent to which survival and growth pathways in the tumour cell (which we seek to inhibit) coincide with those in cardiovascular cells (which we seek to preserve) is an open question but one that will become ever more important with the development of new cancer therapies that target intracellular signalling pathways. It remains unclear whether potential cardiovascular problems can be predicted from analyses of such basic signalling mechanisms and what pre-clinical evaluation should be undertaken. The screening of patients, optimization of therapeutic schemes, monitoring of cardiovascular function during treatment, and the management of cardiovascular side effects are likely to become increasingly important in cancer patients. This paper summarizes the deliberations of a cross-disciplinary workshop organized by the Heart Failure Association of the European Society of Cardiology (held in Brussels in May 2009), which brought together clinicians working in cardiology and oncology and those involved in basic, translational, and pharmaceutical science.
- Published
- 2011
- Full Text
- View/download PDF
15. Regulation of the cardiomyocyte transcriptome vs translatome by endothelin-1 and insulin: translational regulation of 5' terminal oligopyrimidine tract (TOP) mRNAs by insulin.
- Author
-
Markou T, Marshall AK, Cullingford TE, Tham el L, Sugden PH, and Clerk A
- Subjects
- 5' Untranslated Regions genetics, Animals, Base Sequence, Computational Biology, Mice, Molecular Sequence Data, Polyribosomes drug effects, Polyribosomes genetics, Polyribosomes metabolism, RNA, Messenger genetics, Rats, Signal Transduction drug effects, Endothelin-1 pharmacology, Gene Expression Profiling, Insulin pharmacology, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Protein Biosynthesis drug effects, RNA 5' Terminal Oligopyrimidine Sequence genetics
- Abstract
Background: Changes in cellular phenotype result from underlying changes in mRNA transcription and translation. Endothelin-1 stimulates cardiomyocyte hypertrophy with associated changes in mRNA/protein expression and an increase in the rate of protein synthesis. Insulin also increases the rate of translation but does not promote overt cardiomyocyte hypertrophy. One mechanism of translational regulation is through 5' terminal oligopyrimidine tracts (TOPs) that, in response to growth stimuli, promote mRNA recruitment to polysomes for increased translation. TOP mRNAs include those encoding ribosomal proteins, but the full panoply remains to be established. Here, we used microarrays to compare the effects of endothelin-1 and insulin on the global transcriptome of neonatal rat cardiomyocytes, and on mRNA recruitment to polysomes (i.e. the translatome)., Results: Globally, endothelin-1 and insulin (1 h) promoted >1.5-fold significant (false discovery rate < 0.05) changes in expression of 341 and 38 RNAs, respectively. For these transcripts with this level of change there was little evidence of translational regulation. However, 1336 and 712 RNAs had >1.25-fold significant changes in expression in total and/or polysomal RNA induced by endothelin-1 or insulin, respectively, of which approximately 35% of endothelin-1-responsive and approximately 56% of insulin-responsive transcripts were translationally regulated. Of mRNAs for established proteins recruited to polysomes in response to insulin, 49 were known TOP mRNAs with a further 15 probable/possible TOP mRNAs, but 49 had no identifiable TOP sequences or other consistent features in the 5' untranslated region., Conclusions: Endothelin-1, rather than insulin, substantially affects global transcript expression to promote cardiomyocyte hypertrophy. Effects on RNA recruitment to polysomes are subtle, with differential effects of endothelin-1 and insulin on specific transcripts. Furthermore, although insulin promotes recruitment of TOP mRNAs to cardiomyocyte polysomes, not all recruited mRNAs are TOP mRNAs.
- Published
- 2010
- Full Text
- View/download PDF
16. ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes.
- Author
-
Marshall AK, Barrett OP, Cullingford TE, Shanmugasundram A, Sugden PH, and Clerk A
- Subjects
- Animals, Animals, Newborn, Cells, Cultured, Enzyme Inhibitors pharmacology, Gene Expression Profiling, Hypertrophy, Mitogen-Activated Protein Kinase 1 metabolism, Myocytes, Cardiac pathology, RNA, Messenger biosynthesis, Rats, Time Factors, Endothelin-1 pharmacology, Gene Expression Regulation drug effects, Mitogen-Activated Protein Kinase 3 metabolism, Myocytes, Cardiac metabolism, Signal Transduction, rhoA GTP-Binding Protein metabolism
- Abstract
Background: Cardiomyocyte hypertrophy is associated with changes in gene expression. Extracellular signal-regulated kinases 1/2 (ERK1/2) and RhoA [activated by hypertrophic agonists (e.g. endothelin-1)] regulate gene expression and are implicated in the response, but their relative significance in regulating the cardiomyocyte transcriptome is unknown. Our aim was to establish the significance of ERK1/2 and/or RhoA in the early cardiomyocyte transcriptomic response to endothelin-1., Methods/principal Findings: Cardiomyocytes were exposed to endothelin-1 (1 h) with/without PD184352 (to inhibit ERK1/2) or C3 transferase (C3T, to inhibit RhoA). RNA expression was analyzed using microarrays and qPCR. ERK1/2 signaling positively regulated approximately 65% of the early gene expression response to ET-1 with a small (approximately 2%) negative effect, whereas RhoA signaling positively regulated approximately 10% of the early gene expression response to ET-1 with a greater (approximately 14%) negative contribution. Of RNAs non-responsive to endothelin-1, 66 or 448 were regulated by PD184352 or C3T, respectively, indicating that RhoA had a more significant effect on baseline RNA expression. mRNAs upregulated by endothelin-1 encoded a number of receptor ligands (e.g. Ereg, Areg, Hbegf) and transcription factors (e.g. Abra/Srf) that potentially propagate the response., Conclusions/significance: ERK1/2 dominates over RhoA in the early transcriptomic response to endothelin-1. RhoA plays a major role in maintaining baseline RNA expression but, with upregulation of Abra/Srf by endothelin-1, RhoA may regulate changes in RNA expression over longer times. Our data identify ERK1/2 as a more significant node than RhoA in regulating the early stages of cardiomyocyte hypertrophy.
- Published
- 2010
- Full Text
- View/download PDF
17. Dying by the way you live: AIF vs. caspases in apoptosis of hypertrophied cardiomyocytes.
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, DNA Fragmentation, Rats, Apoptosis, Apoptosis Inducing Factor physiology, Cardiomegaly pathology, Caspases physiology, Myocytes, Cardiac pathology
- Published
- 2010
- Full Text
- View/download PDF
18. Regulation of expression of the rat orthologue of mouse double minute 2 (MDM2) by H(2)O(2)-induced oxidative stress in neonatal rat cardiac myocytes.
- Author
-
Pikkarainen S, Kennedy RA, Marshall AK, Tham el L, Lay K, Kriz TA, Handa BS, Clerk A, and Sugden PH
- Subjects
- Animals, Animals, Newborn, Apoptosis drug effects, Apoptosis genetics, Base Sequence, Caspase 3 metabolism, Humans, Introns genetics, Mice, Molecular Sequence Data, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Oxidative Stress genetics, Promoter Regions, Genetic genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Response Elements, Transcription Factor AP-1 genetics, Transcriptional Activation drug effects, Up-Regulation drug effects, Gene Expression Regulation drug effects, Hydrogen Peroxide pharmacology, Myocytes, Cardiac drug effects, Oxidative Stress drug effects, Proto-Oncogene Proteins c-mdm2 genetics, Proto-Oncogene Proteins c-mdm2 metabolism, Sequence Homology, Amino Acid
- Abstract
The Mdm2 ubiquitin ligase is an important regulator of p53 abundance and p53-dependent apoptosis. Mdm2 expression is frequently regulated by a p53 Mdm2 autoregulatory loop whereby p53 stimulates Mdm2 expression and hence its own degradation. Although extensively studied in cell lines, relatively little is known about Mdm2 expression in heart where oxidative stress (exacerbated during ischemia-reperfusion) is an important pro-apoptotic stimulus. We demonstrate that Mdm2 transcript and protein expression are induced by oxidative stress (0.2 mm H(2)O(2)) in neonatal rat cardiac myocytes. In other cells, constitutive Mdm2 expression is regulated by the P1 promoter (5' to exon 1), with inducible expression regulated by the P2 promoter (in intron 1). In myocytes, H(2)O(2) increased Mdm2 expression from the P2 promoter, which contains two p53-response elements (REs), one AP-1 RE, and two Ets REs. H(2)O(2) did not detectably increase expression of p53 mRNA or protein but did increase expression of several AP-1 transcription factors. H(2)O(2) increased binding of AP-1 proteins (c-Jun, JunB, JunD, c-Fos, FosB, and Fra-1) to an Mdm2 AP-1 oligodeoxynucleotide probe, and chromatin immunoprecipitation assays showed it increased binding of c-Jun or JunB to the P2 AP-1 RE. Finally, antisense oligonucleotide-mediated reduction of H(2)O(2)-induced Mdm2 expression increased caspase 3 activation. Thus, increased Mdm2 expression is associated with transactivation at the P2 AP-1 RE (rather than the p53 or Ets REs), and Mdm2 induction potentially represents a cardioprotective response to oxidative stress.
- Published
- 2009
- Full Text
- View/download PDF
19. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.
- Author
-
Sugden PH, Fuller SJ, Weiss SC, and Clerk A
- Subjects
- Animals, Apoptosis physiology, Cardiomegaly pathology, Enzyme Inhibitors therapeutic use, Glycogen Synthase Kinase 3 antagonists & inhibitors, Glycogen Synthase Kinase 3 genetics, Histone Deacetylases metabolism, Humans, Myocytes, Cardiac enzymology, Myocytes, Cardiac pathology, Cardiomegaly drug therapy, Cardiomegaly enzymology, Glycogen Synthase Kinase 3 metabolism, Myocardium enzymology, Signal Transduction drug effects
- Abstract
Glycogen synthase kinase 3 (GSK3, of which there are two isoforms, GSK3alpha and GSK3beta) was originally characterized in the context of regulation of glycogen metabolism, though it is now known to regulate many other cellular processes. Phosphorylation of GSK3alpha(Ser21) and GSK3beta(Ser9) inhibits their activity. In the heart, emphasis has been placed particularly on GSK3beta, rather than GSK3alpha. Importantly, catalytically-active GSK3 generally restrains gene expression and, in the heart, catalytically-active GSK3 has been implicated in anti-hypertrophic signalling. Inhibition of GSK3 results in changes in the activities of transcription and translation factors in the heart and promotes hypertrophic responses, and it is generally assumed that signal transduction from hypertrophic stimuli to GSK3 passes primarily through protein kinase B/Akt (PKB/Akt). However, recent data suggest that the situation is far more complex. We review evidence pertaining to the role of GSK3 in the myocardium and discuss effects of genetic manipulation of GSK3 activity in vivo. We also discuss the signalling pathways potentially regulating GSK3 activity and propose that, depending on the stimulus, phosphorylation of GSK3 is independent of PKB/Akt. Potential GSK3 substrates studied in relation to myocardial hypertrophy include nuclear factors of activated T cells, beta-catenin, GATA4, myocardin, CREB, and eukaryotic initiation factor 2Bvarepsilon. These and other transcription factor substrates putatively important in the heart are considered. We discuss whether cardiac pathologies could be treated by therapeutic intervention at the GSK3 level but conclude that any intervention would be premature without greater understanding of the precise role of GSK3 in cardiac processes.
- Published
- 2008
- Full Text
- View/download PDF
20. Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes.
- Author
-
Cullingford TE, Markou T, Fuller SJ, Giraldo A, Pikkarainen S, Zoumpoulidou G, Alsafi A, Ekere C, Kemp TJ, Dennis JL, Game L, Sugden PH, and Clerk A
- Subjects
- Animals, Cells, Cultured, Endothelin-1 pharmacology, Gene Expression Profiling, Mitogen-Activated Protein Kinase 1 genetics, Mitogen-Activated Protein Kinase 3 genetics, Myocytes, Cardiac drug effects, Oligonucleotide Array Sequence Analysis, Protein Biosynthesis drug effects, Protein Biosynthesis genetics, RNA, Messenger analysis, RNA, Messenger metabolism, Rats, Signal Transduction, Transcription, Genetic, Endothelin-1 physiology, Gene Expression Regulation, Myocytes, Cardiac metabolism
- Abstract
Background: Endothelin-1 stimulates Gq protein-coupled receptors to promote proliferation in dividing cells or hypertrophy in terminally differentiated cardiomyocytes. In cardiomyocytes, endothelin-1 rapidly (within minutes) stimulates protein kinase signaling, including extracellular-signal regulated kinases 1/2 (ERK1/2; though not ERK5), with phenotypic/physiological changes developing from approximately 12 h. Hypertrophy is associated with changes in mRNA/protein expression, presumably consequent to protein kinase signaling, but the connections between early, transient signaling events and developed hypertrophy are unknown., Results: Using microarrays, we defined the early transcriptional responses of neonatal rat cardiomyocytes to endothelin-1 over 4 h, differentiating between immediate early gene (IEG) and second phase RNAs with cycloheximide. IEGs exhibited differential temporal and transient regulation, with expression of second phase RNAs within 1 h. Of transcripts upregulated at 30 minutes encoding established proteins, 28 were inhibited >50% by U0126 (which inhibits ERK1/2/5 signaling), with 9 inhibited 25-50%. Expression of only four transcripts was not inhibited. At 1 h, most RNAs (approximately 67%) were equally changed in total and polysomal RNA with approximately 17% of transcripts increased to a greater extent in polysomes. Thus, changes in expression of most protein-coding RNAs should be reflected in protein synthesis. However, approximately 16% of transcripts were essentially excluded from the polysomes, including some protein-coding mRNAs, presumably inefficiently translated., Conclusion: The phasic, temporal regulation of early transcriptional responses induced by endothelin-1 in cardiomyocytes indicates that, even in terminally differentiated cells, signals are propagated beyond the primary signaling pathways through transcriptional networks leading to phenotypic changes (that is, hypertrophy). Furthermore, ERK1/2 signaling plays a major role in this response.
- Published
- 2008
- Full Text
- View/download PDF
21. Cardiac myocyte gene expression profiling during H2O2-induced apoptosis.
- Author
-
Clerk A, Kemp TJ, Zoumpoulidou G, and Sugden PH
- Subjects
- Animals, Apoptosis drug effects, Blotting, Northern, Computational Biology, DNA Primers, Expressed Sequence Tags, Microarray Analysis, Myocytes, Cardiac drug effects, Proteins metabolism, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction drug effects, Apoptosis physiology, Gene Expression Profiling, Gene Expression Regulation drug effects, Hydrogen Peroxide toxicity, Myocytes, Cardiac metabolism, Oxidative Stress physiology, Proteins genetics
- Abstract
High levels of oxidative stress promote cardiac myocyte death, though lower levels are potentially cytoprotective/anabolic. We examined the changes in gene expression in rat neonatal cardiac myocytes exposed to apoptotic (0.2 mM) or nontoxic (0.04 mM) concentrations of H2O2 (2, 4, or 24 h) using Affymetrix microarrays. Using U34B arrays, we identified a ubiquitously expressed, novel H2O2-responsive gene [putative peroxide-inducible transcript 1 (Perit1)], which generates two alternatively spliced transcripts. Using 230 2.0 arrays, H2O2 (0.04 mM) promoted significant changes in expression of only 32 genes, all of which were seen with 0.2 mM H2O2. We failed to detect any increase in the rate of protein synthesis in cardiac myocytes exposed to <0.1 mM H2O2, further suggesting that global, low concentrations of H2O2 are not anabolic in this system. H2O2 (0.2 mM) promoted significant (P < 0.05, >1.75-fold) changes in expression of 649 mRNAs and 187 RNAs corresponding to no established gene. Of the mRNAs, 114 encoded transcriptional regulators including Krüppel-like factors (Klfs). Quantitative PCR independently verified the changes in Klf expression. Thus, H2O2-induced cardiac myocyte apoptosis is associated with dynamic changes in gene expression. The expression of these genes and their protein products potentially influences the progression of the apoptotic response.
- Published
- 2007
- Full Text
- View/download PDF
22. Inflame my heart (by p38-MAPK).
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, Fibrosis, Gene Expression, Humans, MAP Kinase Signaling System, Myocarditis genetics, Myocarditis metabolism, Myocarditis pathology, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Protein Processing, Post-Translational, Transcription, Genetic, Myocarditis etiology, p38 Mitogen-Activated Protein Kinases metabolism
- Published
- 2006
- Full Text
- View/download PDF
23. Regulation of protein kinase C delta by phorbol ester, endothelin-1, and platelet-derived growth factor in cardiac myocytes.
- Author
-
Markou T, Yong CS, Sugden PH, and Clerk A
- Subjects
- Animals, Animals, Newborn, Cell Culture Techniques, Cell Extracts isolation & purification, Cells, Cultured, Chromatography, Gel, Chromones pharmacology, Enzyme Inhibitors pharmacology, Immunoblotting, Indoles pharmacology, Maleimides pharmacology, Morpholines pharmacology, Phosphorylation drug effects, Precipitin Tests, Protein Kinase C-delta analysis, Protein Kinase C-delta genetics, Pyrimidines pharmacology, Rats, Rats, Sprague-Dawley, Solubility, Time Factors, Endothelin-1 pharmacology, Gene Expression Regulation, Enzymologic drug effects, Myocytes, Cardiac drug effects, Platelet-Derived Growth Factor pharmacology, Protein Kinase C-delta metabolism, Tetradecanoylphorbol Acetate pharmacology
- Abstract
Protein kinase C (PKC) delta is regulated allosterically by phosphatidylserine and diacylglycerol (which promote its translocation to the membrane) and by phosphorylation of Ser/Thr and Tyr residues. Although phosphorylation on Thr-505/Ser-643/Ser-662 may simply "prime" PKCdelta for activation, it could be regulatory. We examined the regulation of PKCdelta in cardiac myocytes by endothelin-1 (Gq protein-coupled receptor agonist) and platelet-derived growth factor (receptor tyrosine kinase agonist) in comparison with phorbol 12-myristate 13-acetate (PMA). All increased phosphorylation of PKCdelta(Thr-505/Ser-643) and of Tyr residues, although to differing extents. De novo phosphorylation occurred mainly after translocation of PKCdelta to the particulate fraction, and phosphorylations of Thr-505/Ser-643 versus Tyr residues were essentially independent events. Following chromatographic separation of the PKCdelta subspecies, activities were correlated with immunoreactivity profiles of total and phosphorylated forms. In unstimulated cells, approximately 25% of PKCdelta lacked phosphorylation of Thr-505/Ser-643 and displayed minimal activity (assayed in the presence of phosphatidylserine/PMA following chromatography). Endothelin-1 or PMA (10 min) promoted Thr-505/Ser-643 phosphorylation of this pool, and this was associated with an increase in total recoverable PKCdelta activity. Meanwhile, in cells exposed to endothelin-1 or PMA, the overall pool of PKCdelta translocated rapidly (30 s) to the particulate fraction and was phosphorylated on Tyr residues. This was associated with an increase in lipid-independent activity (i.e. the phosphatidylserine/PMA requirement disappeared). For endothelin-1, Tyr phosphorylation of PKCdelta and the increase in phosphatidylserine/PMA-independent activity persisted after PKCdelta retrotranslocated to the soluble fraction. We concluded that, with this physiological agonist, PKCdelta becomes activated in the particulate fraction but retains activity following its retrotranslocation, presumably to phosphorylate substrates elsewhere.
- Published
- 2006
- Full Text
- View/download PDF
24. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants.
- Author
-
Sorli SC, Bunney TD, Sugden PH, Paterson HF, and Katan M
- Subjects
- Alternative Splicing physiology, Colorectal Neoplasms metabolism, Gene Expression Regulation, Neoplastic physiology, Humans, Phosphoinositide Phospholipase C, Signal Transduction physiology, Tumor Cells, Cultured, Type C Phospholipases metabolism, ras Proteins metabolism, Alternative Splicing genetics, Signal Transduction genetics, Type C Phospholipases genetics
- Abstract
Phospholipase Cepsilon (PLCepsilon) is a novel member of phosphoinositide-specific phospholipase C enzymes with a unique regulatory link to Ras GTP-ases. In the present studies, we establish existence of two splice variants (PLCepsilon1a and PLCepsilon1b) derived from human PLCepsilon1 gene. When expressed in COS or HEK293 cells, PLCepsilon1a and PLCepsilon1b have similar potential to be stimulated by diverse signaling pathways via tyrosine kinase and G-protein coupled receptors and share the ability to function as an effector of Ras. The expression pattern shows broader mRNA expression of PLCepsilon1a in normal tissues; furthermore, in most cell lines expressing PLCepsilon, PLCepsilon1a is the only splice variant present. Analysis of normal/tumor matched pairs derived from colon and rectum demonstrates greatly reduced expression levels in tumor tissues. Further studies in a colorectal tumor cell line lacking PLCepsilon show restoration of transcription of PLCepsilon1a and PLCepsilon1b by demethylating agent 5-aza-2'-deoxycytidine, suggesting epigenetic silencing through hypermethylation. In addition, expression of exogenous PLCepsilon in this cell line demonstrates inhibitory effects of PLCepsilon on cell viability and proliferation. Taken together, our findings suggest that regulatory mechanisms controlling expression of PLCepsilon, broadened by diversity introduced by splice variants, could play important role in PLCepsilon regulation in normal and tumor cells.
- Published
- 2005
- Full Text
- View/download PDF
25. Ras, Akt, and mechanotransduction in the cardiac myocyte.
- Author
-
Sugden PH
- Subjects
- Animals, Apoptosis physiology, Cell Survival physiology, Humans, Models, Biological, Protein Kinases metabolism, Proto-Oncogene Proteins c-akt, Mechanotransduction, Cellular physiology, Myocytes, Cardiac physiology, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins metabolism, ras Proteins metabolism
- Abstract
The Ras subfamily of 21-kDa ("small") guanine nucleotide binding proteins [which includes Ha-Ras, Ki(A)-Ras, Ki(B)-Ras, and N-Ras] is universally important in regulating intracellular signaling events in mammalian cells and controls their growth, proliferation, senescence, differentiation, and survival. These Ras isoforms act as membrane-associated biological switches that transduce signals from transmembrane receptors, thus potentially activating a variety of downstream signaling proteins. These include ultimately two Ser/Thr protein kinase families, the extracellular signal-regulated kinases 1/2 (ERK1/2) and Akt (or protein kinase B). Activation of ERK1/2 has been associated with cardiac myocyte hypertrophy (ie, increased cell size and myofibrillogenesis, with concurrent transcriptional changes to a fetal pattern of gene expression), whereas activation of Akt is associated with the increased protein accretion in hypertrophy. Both ERK1/2 and Akt may promote myocyte survival. In the intact heart in vivo and in primary cultures of cardiac myocytes, mechanical strain induces hypertrophy, a process known as mechanotransduction, which may involve Ras, ERK1/2, and Akt. In this study, general and cardiospecific aspects of the regulation of Ras and Akt will be described. The various mechanisms through which mechanical strain might initiate Ras- or Akt-dependent signaling will be discussed. The overall conclusion is that although an involvement of Ras and Akt in mechanotransduction is likely, more work (particularly focusing on mechanoreception) needs to be undertaken before it is unequivocally established.
- Published
- 2003
- Full Text
- View/download PDF
26. Phenotyping hypertrophy: eschew obfuscation.
- Author
-
Dorn GW 2nd, Robbins J, and Sugden PH
- Subjects
- Animals, Biomarkers analysis, Cardiomegaly history, Cardiomegaly metabolism, Cardiomegaly pathology, Cell Division, History, 20th Century, Humans, Mice, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Phenotype, Rats, Terminology as Topic, Cardiomegaly classification
- Published
- 2003
- Full Text
- View/download PDF
27. Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein.
- Author
-
Clerk A, Kemp TJ, Harrison JG, Mullen AJ, Barton PJ, and Sugden PH
- Subjects
- Animals, Endothelin-1 pharmacology, JNK Mitogen-Activated Protein Kinases, Myocardium enzymology, Osmotic Pressure, Phenylephrine pharmacology, Proto-Oncogene Proteins c-jun genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Signal Transduction, Tetradecanoylphorbol Acetate pharmacology, Up-Regulation drug effects, Mitogen-Activated Protein Kinases metabolism, Myocardium metabolism, Proto-Oncogene Proteins c-jun metabolism
- Abstract
Cardiac hypertrophy, an important adaptational response, is associated with up-regulation of the immediate early gene, c- jun, which encodes the c-Jun transcription factor. c-Jun may feed back to up-regulate its own transcription and, since the c-Jun N-terminal kinase (JNK) family of mitogen-activated protein kinases (MAPKs) phosphorylate c-Jun(Ser-63/73) to increase its transactivating activity, JNKs are thought to be the principal factors involved in c- jun up-regulation. Hypertrophy in primary cultures of cardiac myocytes is induced by endothelin-1, phenylephrine or PMA, probably through activation of one or more of the MAPK family. These three agonists increased c- jun mRNA with the rank order of potency of PMA approximately endothelin-1>phenylephrine. Up-regulation of c- jun mRNA by endothelin-1 was attenuated by inhibitors of protein kinase C (GF109203X) and the extracellular signal-regulated kinase (ERK) cascade (PD98059 or U0126), but not by inhibitors of the JNK (SP600125) or p38-MAPK (SB203580) cascades. Hyperosmotic shock (0.5 M sorbitol) powerfully activates JNKs, but did not increase c- jun mRNA. These data suggest that ERKs, rather than JNKs, are required for c- jun up-regulation. However, endothelin-1 and phenylephrine induced greater up-regulation of c-Jun protein than PMA and phosphorylation of c-Jun(Ser-63/73) correlated with the level of c-Jun protein. Up-regulation of c-Jun protein by endothelin-1 was attenuated by inhibitors of protein kinase C and the ERK cascade, probably correlating with a primary input of ERKs into transcription. In addition, SP600125 inhibited the phosphorylation of c-Jun(Ser-63/73), attenuated the increase in c-Jun protein induced by endothelin-1 and increased the rate of c-Jun degradation. Thus whereas ERKs are the principal MAPKs required for c- jun transcription, JNKs are necessary to stabilize c-Jun for efficient up-regulation of the protein.
- Published
- 2002
- Full Text
- View/download PDF
28. Untangling the Web: specific signaling from PKC isoforms to MAPK cascades.
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, Apoptosis physiology, Humans, Isoenzymes metabolism, Second Messenger Systems physiology, MAP Kinase Signaling System physiology, Myocardium enzymology, Protein Kinase C metabolism, Signal Transduction physiology
- Published
- 2001
29. Akt like a woman: gender differences in susceptibility to cardiovascular disease.
- Author
-
Sugden PH and Clerk A
- Subjects
- Animals, Apoptosis drug effects, Apoptosis physiology, Cardiovascular Diseases epidemiology, Cardiovascular System enzymology, Cytoprotection physiology, Disease Susceptibility enzymology, Enzyme Activation drug effects, Enzyme Activation physiology, Estrogens metabolism, Estrogens pharmacology, Female, Glycogen metabolism, Humans, Insulin-Like Growth Factor I genetics, Insulin-Like Growth Factor I metabolism, Isoenzymes metabolism, Male, Mice, Mice, Transgenic, Myocardium cytology, Myocardium enzymology, Phosphatidylinositol Phosphates metabolism, Proto-Oncogene Proteins c-akt, Sex Factors, Signal Transduction drug effects, Signal Transduction physiology, Transcription Factors metabolism, Cardiovascular Diseases enzymology, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins metabolism
- Published
- 2001
- Full Text
- View/download PDF
30. Mechanotransduction in cardiomyocyte hypertrophy.
- Author
-
Sugden PH
- Subjects
- Humans, Hypertrophy, Left Ventricular enzymology, Hypertrophy, Left Ventricular metabolism, Hypertrophy, Left Ventricular pathology, Mitogen-Activated Protein Kinases metabolism, Myocardial Contraction, Myocardium enzymology, Signal Transduction, Hypertrophy, Left Ventricular physiopathology, Myocardium metabolism
- Published
- 2001
- Full Text
- View/download PDF
31. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1.
- Author
-
Clerk A, Pham FH, Fuller SJ, Sahai E, Aktories K, Marais R, Marshall C, and Sugden PH
- Subjects
- Animals, Atrial Natriuretic Factor genetics, Cardiomegaly etiology, Cells, Cultured, Endothelin-1 pharmacology, Enzyme Activation drug effects, Gene Expression Regulation, Guanosine Triphosphate metabolism, Humans, Myocardium cytology, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins c-raf metabolism, Rats, Transfection, rhoA GTP-Binding Protein metabolism, MAP Kinase Kinase Kinase 1, Mitogen-Activated Protein Kinases metabolism, Myocardium metabolism, rac1 GTP-Binding Protein metabolism
- Abstract
Small guanine nucleotide-binding proteins of the Ras and Rho (Rac, Cdc42, and Rho) families have been implicated in cardiac myocyte hypertrophy, and this may involve the extracellular signal-related kinase (ERK), c-Jun N-terminal kinase (JNK), and/or p38 mitogen-activated protein kinase (MAPK) cascades. In other systems, Rac and Cdc42 have been particularly implicated in the activation of JNKs and p38-MAPKs. We examined the activation of Rho family small G proteins and the regulation of MAPKs through Rac1 in cardiac myocytes. Endothelin 1 and phenylephrine (both hypertrophic agonists) induced rapid activation of endogenous Rac1, and endothelin 1 also promoted significant activation of RhoA. Toxin B (which inactivates Rho family proteins) attenuated the activation of JNKs by hyperosmotic shock or endothelin 1 but had no effect on p38-MAPK activation. Toxin B also inhibited the activation of the ERK cascade by these stimuli. In transfection experiments, dominant-negative N17Rac1 inhibited activation of ERK by endothelin 1, whereas activated V12Rac1 cooperated with c-Raf to activate ERK. Rac1 may stimulate the ERK cascade either by promoting the phosphorylation of c-Raf or by increasing MEK1 and/or -2 association with c-Raf to facilitate MEK1 and/or -2 activation. In cardiac myocytes, toxin B attenuated c-Raf(Ser-338) phosphorylation (50 to 70% inhibition), but this had no effect on c-Raf activity. However, toxin B decreased both the association of MEK1 and/or -2 with c-Raf and c-Raf-associated ERK-activating activity. V12Rac1 cooperated with c-Raf to increase expression of atrial natriuretic factor (ANF), whereas N17Rac1 inhibited endothelin 1-stimulated ANF expression, indicating that the synergy between Rac1 and c-Raf is potentially physiologically important. We conclude that activation of Rac1 by hypertrophic stimuli contributes to the hypertrophic response by modulating the ERK and/or possibly the JNK (but not the p38-MAPK) cascades.
- Published
- 2001
- Full Text
- View/download PDF
32. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes.
- Author
-
Pham FH, Sugden PH, and Clerk A
- Subjects
- Animals, Cells, Cultured, Eukaryotic Initiation Factor-4E, Intracellular Signaling Peptides and Proteins, Muscle Proteins biosynthesis, Myocardium cytology, Peptide Initiation Factors metabolism, Phosphorylation, Proto-Oncogene Proteins c-akt, RNA Cap Analogs metabolism, Rats, Rats, Sprague-Dawley, Sepharose metabolism, Carrier Proteins, Myocardium metabolism, Oxidative Stress physiology, Phosphoproteins metabolism, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins metabolism
- Abstract
Stimulation of phosphatidylinositol 3'-kinase (PI3K) and protein kinase B (PKB) is implicated in the regulation of protein synthesis in various cells. One mechanism involves PI3K/PKB-dependent phosphorylation of 4E-BP1, which dissociates from eIF4E, allowing initiation of translation from the 7-methylGTP cap of mRNAs. We examined the effects of insulin and H(2)O(2) on this pathway in neonatal cardiac myocytes. Cardiac myocyte protein synthesis was increased by insulin, but was inhibited by H(2)O(2). PI3K inhibitors attenuated basal levels of protein synthesis and inhibited the insulin-induced increase in protein synthesis. Insulin or H(2)O(2) increased the phosphorylation (activation) of PKB through PI3K, but, whereas insulin induced a sustained response, the response to H(2)O(2) was transient. 4E-BP1 was phosphorylated in unstimulated cells, and 4E-BP1 phosphorylation was increased by insulin. H(2)O(2) stimulated dephosphorylation of 4E-BP1 by increasing protein phosphatase (PP1/PP2A) activity. This increased the association of 4E-BP1 with eIF4E, consistent with H(2)O(2) inhibition of protein synthesis. The effects of H(2)O(2) were sufficient to override the stimulation of protein synthesis and 4E-BP1 phosphorylation induced by insulin. These results indicate that PI3K and PKB are important regulators of protein synthesis in cardiac myocytes, but other factors, including phosphatase activity, modulate the overall response.
- Published
- 2000
- Full Text
- View/download PDF
33. Small guanine nucleotide-binding proteins and myocardial hypertrophy.
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, Humans, Signal Transduction, ras Proteins physiology, rho GTP-Binding Proteins physiology, Cardiomegaly etiology, Monomeric GTP-Binding Proteins physiology
- Abstract
The small (21 kDa) guanine nucleotide-binding protein (small G protein) superfamily comprises 5 subfamilies (Ras, Rho, ADP ribosylation factors [ARFs], Rab, and Ran) that act as molecular switches to regulate numerous cellular responses. Cardiac myocyte hypertrophy is associated with cell growth and changes in the cytoskeleton and myofibrillar apparatus. In other cells, the Ras subfamily regulates cell growth whereas the Rho subfamily (RhoA, Rac1, and Cdc42) regulates cell morphology. Thus, the involvement of small G proteins in hypertrophy has become an area of significant interest. Hearts from transgenic mice expressing activated Ras develop features consistent with hypertrophy, whereas mice overexpressing RhoA develop lethal heart failure. In isolated neonatal rat cardiac myocytes, transfection or infection with activated Ras, RhoA, or Rac1 induces many of the features of hypertrophy. We discuss the mechanisms of activation of the small G proteins and the downstream signaling pathways involved. The latter may include protein kinases, particularly the mitogen-activated or Rho-activated protein kinases. We conclude that although there is significant evidence implicating Ras, RhoA, and Rac1 in hypertrophy, the mechanisms are not fully understood.
- Published
- 2000
- Full Text
- View/download PDF
34. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential.
- Author
-
Cook SA, Sugden PH, and Clerk A
- Subjects
- Animals, Apoptosis physiology, Carrier Proteins metabolism, Cytochrome c Group metabolism, Hydrogen Peroxide pharmacology, Membrane Potentials physiology, Mitochondria, Heart physiology, Myocardium cytology, Oxidants pharmacology, Rats, Rats, Sprague-Dawley, Subcellular Fractions metabolism, Tissue Distribution physiology, bcl-Associated Death Protein, Aging metabolism, Myocardium metabolism, Oxidative Stress physiology, Proto-Oncogene Proteins c-bcl-2 metabolism
- Abstract
Cardiac myocyte apoptosis is potentially important in many cardiac disorders. In other cells, Bcl-2 family proteins and mitochondrial dysfunction are probably key regulators of the apoptotic response. In the present study, we characterized the regulation of antiapoptotic (Bcl-2, Bcl-xL) and proapoptotic (Bad, Bax) Bcl-2 family proteins in the rat heart during development and in oxidative stress-induced apoptosis. Bcl-2 and Bcl-xL were expressed at high levels in the neonate, and their expression was sustained during development. In contrast, although Bad and Bax were present at high levels in neonatal hearts, they were barely detectable in adult hearts. We confirmed that H(2)O(2) induced cardiac myocyte cell death, stimulating poly(ADP-ribose) polymerase proteolysis (from 2 hours), caspase-3 proteolysis (from 2 hours), and DNA fragmentation (from 8 hours). In unstimulated neonatal cardiac myocytes, Bcl-2 and Bcl-xL were associated with the mitochondria, but Bad and Bax were predominantly present in a crude cytosolic fraction. Exposure of myocytes to H(2)O(2) stimulated rapid translocation of Bad (<5 minutes) to the mitochondria. This was followed by the subsequent degradation of Bad and Bcl-2 (from approximately 30 minutes). The levels of the mitochondrial membrane marker cytochrome oxidase remained unchanged. H(2)O(2) also induced translocation of cytochrome c from the mitochondria to the cytosol within 15 to 30 minutes, which was indicative of mitochondrial dysfunction. Myocytes exposed to H(2)O(2) showed an early loss of mitochondrial membrane potential (assessed by fluorescence-activated cell sorter analysis) from 15 to 30 minutes, which was partially restored by approximately 1 hour. However, a subsequent irreversible loss of mitochondrial membrane potential occurred that correlated with cell death. These data suggest that the regulation of Bcl-2 and mitochondrial function are important factors in oxidative stress-induced cardiac myocyte apoptosis.
- Published
- 1999
- Full Text
- View/download PDF
35. Regulation of Ras.GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. Activation of the extracellular signal-regulated kinase cascade by phorbol ester is mediated by Ras.
- Author
-
Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ, and Sugden PH
- Subjects
- Animals, Cells, Cultured, Cyclic AMP pharmacology, Down-Regulation drug effects, Endothelin-1 pharmacology, Enzyme Activation, MAP Kinase Kinase 1, Pertussis Toxin, Phenylephrine pharmacology, Phosphorylation, Protein Binding drug effects, Protein Kinase C antagonists & inhibitors, Protein Serine-Threonine Kinases metabolism, Protein-Tyrosine Kinases metabolism, Rats, Rats, Sprague-Dawley, Virulence Factors, Bordetella pharmacology, GTP-Binding Proteins agonists, Guanosine Triphosphate metabolism, Heart Ventricles metabolism, Mitogen-Activated Protein Kinase Kinases, Proto-Oncogene Proteins c-raf metabolism, Tetradecanoylphorbol Acetate pharmacology, ras Proteins metabolism
- Abstract
The small G protein Ras has been implicated in hypertrophy of cardiac myocytes. We therefore examined the activation (GTP loading) of Ras by the following hypertrophic agonists: phorbol 12-myristate 13-acetate (PMA), endothelin-1 (ET-1), and phenylephrine (PE). All three increased Ras.GTP loading by 10-15-fold (maximal in 1-2 min), as did bradykinin. Other G protein-coupled receptor agonists (e.g. angiotensin II, carbachol, isoproterenol) were less effective. Activation of Ras by PMA, ET-1, or PE was reduced by inhibition of protein kinase C (PKC), and that induced by ET-1 or PE was partly sensitive to pertussis toxin. 8-(4-Chlorophenylthio)-cAMP (CPT-cAMP) did not inhibit Ras.GTP loading by PMA, ET-1, or PE. The association of Ras with c-Raf protein was increased by PMA, ET-1, or PE, and this was inhibited by CPT-cAMP. However, only PMA and ET-1 increased Ras-associated mitogen-activated protein kinase kinase 1-activating activity, and this was decreased by PKC inhibition, pertussis toxin, and CPT-cAMP. PMA caused the rapid appearance of phosphorylated (activated) extracellular signal-regulated kinase in the nucleus, which was inhibited by a microinjected neutralizing anti-Ras antibody. We conclude that PKC- and Gi-dependent mechanisms mediate the activation of Ras in myocytes and that Ras activation is required for stimulation of extracellular signal-regulated kinase by PMA.
- Published
- 1999
- Full Text
- View/download PDF
36. Signaling in myocardial hypertrophy: life after calcineurin?
- Author
-
Sugden PH
- Subjects
- Animals, Humans, Hypertrophy, Left Ventricular enzymology, Hypertrophy, Right Ventricular enzymology, Signal Transduction, Calcineurin physiology, Hypertrophy, Left Ventricular physiopathology, Hypertrophy, Right Ventricular physiopathology
- Published
- 1999
- Full Text
- View/download PDF
37. Stimulation of gene expression in neonatal rat ventricular myocytes by Ras is mediated by Ral guanine nucleotide dissociation stimulator (Ral.GDS) and phosphatidylinositol 3-kinase in addition to Raf.
- Author
-
Fuller SJ, Finn SG, Downward J, and Sugden PH
- Subjects
- Actins genetics, Actins metabolism, Animals, Atrial Natriuretic Factor genetics, Atrial Natriuretic Factor metabolism, Cell Size, Cells, Cultured, GTP-Binding Proteins genetics, Gene Expression Regulation, Genes, fos, Heart Ventricles cytology, Humans, Luciferases genetics, Luciferases metabolism, Mutation, Phosphatidylinositol 3-Kinases genetics, Proto-Oncogene Proteins c-raf metabolism, Rats, Rats, Sprague-Dawley, Recombinant Proteins drug effects, Recombinant Proteins genetics, Recombinant Proteins metabolism, Response Elements, ral Guanine Nucleotide Exchange Factor, rap GTP-Binding Proteins, GTP-Binding Proteins metabolism, Genes, ras, Heart Ventricles metabolism, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-raf genetics
- Abstract
Treatment of cultured neonatal ventricular myocytes with oncogenic Ras increases their size and stimulates the re-expression of genes which are normally restricted to the fetal stage of ventricular development, including atrial natriuretic factor (ANF) and skeletal muscle (SkM)-alpha-actin. To determine which signalling pathways mediate these responses, myocytes were transfected with oncogenic (V12) Ras mutants which interact selectively with different effectors and their effects on luciferase (LUX) reporter plasmids were examined. V12 human Ras (V12HRas), itself, activated ANF-LUX 9. 6-fold, whereas mutants of V12HRas, which selectively stimulate Ral guanine nucleotide dissociation stimulator (Ral.GDS) (E37G), c-Raf (D38E) and phosphatidylinositol 3-kinase (PI-3-K; Y40C) enhanced ANF-LUX expression 3.0-, 3.7- and 1.7-fold respectively. The full response of ANF-LUX to V12HRas was restored by using a combination of the individual effector domain mutants. Likewise, SkM-alpha-actin-LUX expression was activated 12.0-, 3.5-, 4.5- and 3. 0-fold by V12HRas, E37G, D38E and Y40C respectively, and a similar pattern of activation was also observed using a c-fos serum-response element-LUX reporter gene. Cell size was also increased by each of the mutants, but simultaneous expression of all three mutant constructs was needed to reconstitute the full effect of V12HRas on cell size (50% increase). Transfection with a constitutively active mutant of PI-3-K (p110K227E) stimulated ANF-LUX, SkM-alpha-actin-LUX, c-fos-serum-response element-LUX and Rous sarcoma virus-LUX by 3.1-, 3.2-, 2.1- and 2.9-fold respectively, but the co-transfected cytomegalovirus-beta-galactosidase reporter gene was activated to a similar extent (1.9-fold). These results suggest that Raf, Ral.GDS and PI-3-K can all transduce transcriptional responses to V12HRas, but that the specific induction of genes associated with the hypertrophic response is not mediated through PI-3-K.
- Published
- 1998
- Full Text
- View/download PDF
38. Cellular mechanisms of cardiac hypertrophy.
- Author
-
Sugden PH and Clerk A
- Subjects
- Animals, Cardiomegaly pathology, Humans, Cardiomegaly metabolism, Signal Transduction
- Abstract
Hypertrophy of myocytes in the heart ventricles is an important adaptation that in vivo occurs in response to a requirement for increased contractile power. It involves changes at the level of gene transcription, stimulation of the rate of protein synthesis (translation), and increased assembly of myofibrils. There is mounting evidence of the involvement of reversible protein phosphorylation and dephosphorylation in most of these processes. Protein kinase C, mitogen-activated protein kinases, and transcription factors have been implicated in the modulation of the transcriptional changes. Activation of translation may also be mediated through protein phosphorylation/dephosphorylation, although this has not been clearly established in the heart. Here we provide a critical overview of the signalling pathways involved in the hypertrophic response and provide a scheme to account for many of its features.
- Published
- 1998
- Full Text
- View/download PDF
39. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning.
- Author
-
Zhao J, Renner O, Wightman L, Sugden PH, Stewart L, Miller AD, Latchman DS, and Marber MS
- Subjects
- Animals, Animals, Newborn, Cell Membrane Permeability, Cell Survival, Cells, Cultured, Genes, Reporter, Myocardial Infarction prevention & control, Myocardium cytology, Protein Kinase C antagonists & inhibitors, Rats, Rats, Sprague-Dawley, Recombinant Proteins biosynthesis, Staurosporine pharmacology, Time Factors, Transfection, beta-Galactosidase biosynthesis, beta-Galactosidase genetics, Ischemic Preconditioning, Myocardial methods, Isoenzymes biosynthesis, Myocardial Ischemia metabolism, Myocardium enzymology, Protein Kinase C biosynthesis
- Abstract
The role of protein kinase C (PKC) in ischemic preconditioning remains controversial because of difficulties with both its measurement and pharmacological manipulation. We investigated preconditioning in isolated neonatal rat cardiocytes by expressing constitutively active isotypes of PKC. Observations at differing durations of simulated ischemia suggested beta-galactosidase (beta-gal) activity reflected viability within transfected myocytes. Preconditioning with 90 min of ischemia significantly increased beta-gal activity and myocyte survival after 6 h of ischemia; an effect abolished by PKC inhibitors. After co-transfection with plasmids encoding beta-gal and either constitutively active mutants of PKC-delta, PKC-alpha, wild type PKC-delta, or empty vector, cardiocytes were subjected to 6 h of ischemia. Only PKC-delta, rendered constitutively active by a limited deletion within the pseudosubstrate domain, consistently increased resistance to simulated ischemia (beta-gal activity was 85.6 +/- 11.9% versus 53.7 +/- 6.5% (p = 0.01) and dead myocytes 46.8 +/- 3.4% versus 68.7 +/- 2.8% (p = 0.01)). Since transfection was apparent in only 5-12% of cells, the results suggested a protective bystander effect that was confirmed by co-culture of transfected myocytes with untransfected myocytes. In neonatal cardiocytes expression of active PKC-delta increases resistance to simulated ischemia. This observation may provide further insight into the mechanism and possible avenues for therapeutic exploitation of preconditioning.
- Published
- 1998
- Full Text
- View/download PDF
40. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart.
- Author
-
Haq SE, Clerk A, and Sugden PH
- Subjects
- Animals, Enzyme Activation, Ischemic Preconditioning, Myocardial, Male, Phosphorylation, Rats, Rats, Sprague-Dawley, Adenosine pharmacology, Calcium-Calmodulin-Dependent Protein Kinases metabolism
- Abstract
Adenosine and mitogen-activated protein kinases (MAPKs) have been separately implicated in cardiac ischaemic preconditioning. We investigated the activation of MAPK subfamilies by adenosine in perfused rat hearts. p38-MAPK was rapidly phosphorylated and activated (10-fold activation, maximal at 5 min) by 10 mM adenosine, as was the p38-MAPK substrate, MAPKAPK2 (4.5-fold). SAPKs/JNKs were activated (5-fold) and ERKs were phosphorylated (both maximal at 5 min). The concentration dependences of activation of p38-MAPK and ERKs were biphasic with a 'high affinity' component (maximal at 10-100 microM adenosine) and a 'low affinity' component that had not saturated at 10 mM. SAPKs/JNKs were activated only by 10 mM adenosine. These results are consistent with MAPK involvement in adenosine-mediated ischaemic preconditioning.
- Published
- 1998
- Full Text
- View/download PDF
41. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium.
- Author
-
Sugden PH and Clerk A
- Subjects
- Animals, Cardiomegaly physiopathology, Enzyme Activation physiology, Humans, JNK Mitogen-Activated Protein Kinases, Substrate Specificity, p38 Mitogen-Activated Protein Kinases, Calcium-Calmodulin-Dependent Protein Kinases physiology, Mitogen-Activated Protein Kinases, Myocardium enzymology, Stress, Physiological physiopathology
- Published
- 1998
- Full Text
- View/download PDF
42. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes.
- Author
-
Clerk A, Michael A, and Sugden PH
- Subjects
- Amino Acid Sequence, Animals, Cells, Cultured, Enzyme Activation, HSP27 Heat-Shock Proteins, Heart Ventricles cytology, Hydrogen Peroxide pharmacology, Intracellular Signaling Peptides and Proteins, MAP Kinase Kinase 4, Molecular Sequence Data, Myocardium cytology, Myocardium enzymology, Phosphorylation, Protein Kinases metabolism, Protein Serine-Threonine Kinases metabolism, Rats, Rats, Sprague-Dawley, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Heat-Shock Proteins metabolism, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase Kinase 1, Mitogen-Activated Protein Kinase Kinases, Myocardium metabolism, Neoplasm Proteins metabolism, Oxidative Stress physiology
- Abstract
We investigated the activation of three subfamilies of mitogen-activated protein kinases (MAPKs), namely the stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs), the extracellularly responsive kinases (ERKs) and p38-MAPK, by oxidative stress as exemplified by H2O2 in primary cultures of neonatal rat ventricular myocytes. The 46 and 54 kDa species of SAPKs/JNKs were activated 5- and 10-fold, respectively, by 0.1 mM H2O2 (the maximally effective concentration). Maximal activation occurred at 15-30 min, but was still detectable after 2 h. Both ERK1 and ERK2 were activated 16-fold by 0.1 mM H2O2 with a similar time course to the SAPKs/JNKs, and this was comparable with their activation by 1 microM PMA, the most powerful activator of ERKs that we have so far identified in these cells. The activation of ERKs by H2O2 was inhibited by PD98059, which inhibits the activation of MAPK (or ERK) kinases, and by the protein kinase C (PKC) inhibitor, GF109203X. ERK activation was also inhibited by down-regulation of PMA-sensitive PKC isoforms. p38-MAPK was activated by 0.1 mM H2O2 as shown by an increase in its phosphorylation. However, maximal phosphorylation (activation) was more rapid (<5 min) than for the SAPKs/JNKs or the ERKs. We studied the downstream consequences of p38-MAPK activation by examining activation of MAPK-activated protein kinase 2 (MAPKAPK2) and phosphorylation of the MAPKAPK2 substrate, the small heat shock protein HSP25/27. As with p38-MAPK, MAPKAPK2 was rapidly activated (maximal within 5 min) by 0.1 mM H2O2. This activation was abolished by 10 microM SB203580, a selective inhibitor of certain p38-MAPK isoforms. The phosphorylation of HSP25/27 rapidly followed activation of MAPKAPK2 and was also inhibited by SB203580. Phosphorylation of HSP25/27 was associated with a decrease in its aggregation state. These data indicate that oxidative stress is a powerful activator of all three MAPK subfamilies in neonatal rat ventricular myocytes. Activation of all three MAPKs has been associated with the development of the hypertrophic phenotype. However, stimulation of p38-MAPK and the consequent phosphorylation of HSP25/27 may also be important in cardioprotection.
- Published
- 1998
- Full Text
- View/download PDF
43. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?
- Author
-
Clerk A, Michael A, and Sugden PH
- Subjects
- Animals, Animals, Newborn, Cardiomegaly enzymology, Cardiomegaly etiology, Cell Size drug effects, Cell Survival drug effects, Cells, Cultured, Endothelin-1 pharmacology, Enzyme Activation drug effects, Enzyme Inhibitors pharmacology, GTP-Binding Proteins metabolism, Heart Ventricles drug effects, Heart Ventricles metabolism, Heart Ventricles pathology, Hypertrophy, Intracellular Signaling Peptides and Proteins, Myocardium metabolism, Myocardium pathology, Phenylephrine pharmacology, Phosphorylation, Protein Kinase C metabolism, Protein Serine-Threonine Kinases metabolism, Rats, Receptors, Cell Surface drug effects, Receptors, Cell Surface metabolism, Virulence Factors, Bordetella pharmacology, p38 Mitogen-Activated Protein Kinases, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Mitogen-Activated Protein Kinases, Myocardium enzymology
- Abstract
We examined the activation of the p38 mitogen-activated protein kinase (p38-MAPK) pathway by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine in primary cultures of cardiac myocytes from neonatal rat hearts. Both agonists increased the phosphorylation (activation) of p38-MAPK by approximately 12-fold. A p38-MAPK substrate, MAPK-activated protein kinase 2 (MAPKAPK2), was activated approximately fourfold and 10 microM SB203580, a p38-MAPK inhibitor, abolished this activation. Phosphorylation of the MAPKAPK2 substrate, heat shock protein 25/27, was also increased. Using selective inhibitors, activation of the p38-MAPK pathway by endothelin-1 was shown to involve protein kinase C but not Gi/Go nor the extracellularly responsive kinase (ERK) pathway. SB203580 failed to inhibit the morphological changes associated with cardiac myocyte hypertrophy induced by endothelin-1 or phenylephrine between 4 and 24 h. However, it decreased the myofibrillar organization and cell profile at 48 h. In contrast, inhibition of the ERK cascade with PD98059 prevented the increase in myofibrillar organization but not cell profile. These data are not consistent with a role for the p38-MAPK pathway in the immediate induction of the morphological changes of hypertrophy but suggest that it may be necessary over a longer period to maintain the response.
- Published
- 1998
- Full Text
- View/download PDF
44. Oncogenic src, raf, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes.
- Author
-
Fuller SJ, Gillespie-Brown J, and Sugden PH
- Subjects
- Actins metabolism, Animals, Atrial Natriuretic Factor pharmacology, Cell Size, Cells, Cultured, Genes, Reporter, Genistein pharmacology, Growth Inhibitors pharmacology, Luciferases genetics, Myosin Heavy Chains pharmacology, Oncogene Proteins v-raf, Promoter Regions, Genetic drug effects, Rats, Rats, Sprague-Dawley, Retroviridae Proteins, Oncogenic pharmacology, Transfection, src-Family Kinases genetics, src-Family Kinases metabolism, Gene Expression Regulation, Developmental drug effects, Genes, ras, Genes, src, Heart growth & development, Myocardium cytology, Proto-Oncogene Proteins c-raf genetics
- Abstract
In response to hormones and growth factors, cultured neonatal ventricular myocytes increase in profile, exhibit myofibrillogenesis, and re-express genes whose expression is normally restricted to the fetal stage of ventricular development. These include atrial natriuretic factor (ANF), beta-myosin heavy chain (beta-MHC), and skeletal muscle (SkM)-alpha-actin. By using luciferase reporter plasmids, we examined whether oncogenes that activate the extracellular signal-regulated kinase cascade (srcF527, Ha-rasV12, and v-raf) increased expression of "fetal" genes. Transfection of myocytes with srcF527 stimulated expression of ANF, SkM-alpha-actin, and beta-MHC by 62-, 6.7-, and 50-fold, respectively, but did not induce DNA synthesis. Stimulation of ANF expression by srcF527 was greater than by Ha-rasV12, which in turn was greater than by v-raf. General gene expression was also increased but to a lesser extent. The response to srcF527 was inhibited by dominant-negative Ha-rasN17. Myocyte area was increased by srcF527, Ha-rasV12, and v-raf, and although it altered myocyte morphology by causing a pseudopodial appearance, srcF527 did not detectably increase myofibrillogenesis either alone or in combination with Ha-rasV12. A kinase-dead src mutant increased myocyte size to a much lesser extent than srcF527 and also did not inhibit ANF-luciferase expression in response to phenylephrine. We conclude that members of the Src family of tyrosine kinases may be important in mediating the transcriptional changes occurring during cardiac myocyte hypertrophy and that Ras and Raf may be downstream effectors.
- Published
- 1998
- Full Text
- View/download PDF
45. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart.
- Author
-
Lazou A, Sugden PH, and Clerk A
- Subjects
- Adrenergic alpha-Agonists pharmacology, Animals, Enzyme Activation drug effects, Heart drug effects, Imidazoles pharmacology, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, Male, Myocardial Ischemia metabolism, Phosphorylation, Protein Serine-Threonine Kinases metabolism, Pyridines pharmacology, Rats, Rats, Sprague-Dawley, Reperfusion, Tetradecanoylphorbol Acetate pharmacology, p38 Mitogen-Activated Protein Kinases, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Heart physiology, Mitogen-Activated Protein Kinases, Phenylephrine pharmacology, Receptors, Cell Surface agonists
- Abstract
We investigated the ability of phenylephrine (PE), an alpha-adrenergic agonist and promoter of hypertrophic growth in the ventricular myocyte, to activate the three best-characterized mitogen-activated protein kinase (MAPK) subfamilies, namely p38-MAPKs, SAPKs/JNKs (i.e. stress-activated protein kinases/c-Jun N-terminal kinases) and ERKs (extracellularly responsive kinases), in perfused contracting rat hearts. Perfusion of hearts with 100 microM PE caused a rapid (maximal at 10 min) 12-fold activation of two p38-MAPK isoforms, as measured by subsequent phosphorylation of a p38-MAPK substrate, recombinant MAPK-activated protein kinase 2 (MAPKAPK2). This activation coincided with phosphorylation of p38-MAPK. Endogenous MAPKAPK2 was activated 4-5-fold in these perfusions and this was inhibited completely by the p38-MAPK inhibitor, SB203580 (10 microM). Activation of p38-MAPK and MAPKAPK2 was also detected in non-contracting hearts perfused with PE, indicating that the effects were not dependent on the positive inotropic/chronotropic properties of the agonist. Although SAPKs/JNKs were also rapidly activated, the activation (2-3-fold) was less than that of p38-MAPK. The ERKs were activated by perfusion with PE and the activation was at least 50% of that seen with 1 microM PMA, the most powerful activator of the ERKs yet identified in cardiac myocytes. These results indicate that, in addition to the ERKs, two MAPK subfamilies, whose activation is more usually associated with cellular stresses, are activated by the Gq/11-protein-coupled receptor (Gq/11PCR) agonist, PE, in whole hearts. These data indicate that Gq/11PCR agonists activate multiple MAPK signalling pathways in the heart, all of which may contribute to the overall response (e.g. the development of the hypertrophic phenotype).
- Published
- 1998
- Full Text
- View/download PDF
46. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs).
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, Animals, Newborn, Enzyme Activation drug effects, JNK Mitogen-Activated Protein Kinases, Myocardium enzymology, Rats, p38 Mitogen-Activated Protein Kinases, Calcium-Calmodulin-Dependent Protein Kinases antagonists & inhibitors, Enzyme Inhibitors pharmacology, Imidazoles pharmacology, Mitogen-Activated Protein Kinases, Pyridines pharmacology
- Abstract
SB203580 is a recognised inhibitor of p38-MAPKs. Here, we investigated the effects of SB203580 on cardiac SAPKs/JNKs. The IC50 for inhibition of p38-MAPK stimulation of MAPKAPK2 was approximately 0.07 microM, whereas that for total SAPK/JNK activity was 3-10 microM. SB203580 did not inhibit immunoprecipitated JNK1 isoforms. Three peaks of SAPK/JNK activity were separated by anion exchange chromatography, eluting in the isocratic wash (44 kDa), and at 0.08 M (46 and 52 kDa) and 0.15 M NaCl (54 kDa). SB203580 (10 microM) completely inhibited the 0.15 M NaCl activity and partially inhibited the 0.08 M NaCl activity. Since JNK1 antibodies immunoprecipitate the 46 kDa activity, this indicates that SB203580 selectively inhibits 52 and 54 kDa SAPKs/JNKs.
- Published
- 1998
- Full Text
- View/download PDF
47. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses.
- Author
-
Clerk A, Fuller SJ, Michael A, and Sugden PH
- Subjects
- Amino Acid Sequence, Animals, Chromatography, High Pressure Liquid, Enzyme Activation, Enzyme Inhibitors pharmacology, Free Radical Scavengers metabolism, Heart drug effects, Humans, Hydrogen Peroxide pharmacology, Imidazoles pharmacology, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, Male, Molecular Sequence Data, Myocardial Ischemia enzymology, Myocardial Reperfusion, Perfusion, Pyridines pharmacology, Rats, Rats, Sprague-Dawley, p38 Mitogen-Activated Protein Kinases, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Mitogen-Activated Protein Kinases, Myocardium enzymology, Oxidative Stress, Protein Serine-Threonine Kinases metabolism
- Abstract
"Stress-regulated" mitogen-activated protein kinases (SR-MAPKs) comprise the stress-activated protein kinases (SAPKs)/c-Jun N-terminal kinases (JNKs) and the p38-MAPKs. In the perfused heart, ischemia/reperfusion activates SR-MAPKs. Although the agent(s) directly responsible is unclear, reactive oxygen species are generated during ischemia/reperfusion. We have assessed the ability of oxidative stress (as exemplified by H2O2) to activate SR-MAPKs in the perfused heart and compared it with the effect of ischemia/reperfusion. H2O2 activated both SAPKs/JNKs and p38-MAPK. Maximal activation by H2O2 in both cases was observed at 0.5 mM. Whereas activation of p38-MAPK by H2O2 was comparable to that of ischemia and ischemia/reperfusion, activation of the SAPKs/JNKs was less than that of ischemia/reperfusion. As with ischemia/reperfusion, there was minimal activation of the ERK MAPK subfamily by H2O2. MAPK-activated protein kinase 2 (MAPKAPK2), a downstream substrate of p38-MAPKs, was activated by H2O2 to a similar extent as with ischemia or ischemia/reperfusion. In all instances, activation of MAPKAPK2 in perfused hearts was inhibited by SB203580, an inhibitor of p38-MAPKs. Perfusion of hearts at high aortic pressure (20 kilopascals) also activated the SR-MAPKs and MAPKAPK2. Free radical trapping agents (dimethyl sulfoxide and N-t-butyl-alpha-phenyl nitrone) inhibited the activation of SR-MAPKs and MAPKAPK2 by ischemia/reperfusion. These data are consistent with a role for reactive oxygen species in the activation of SR-MAPKs during ischemia/reperfusion.
- Published
- 1998
- Full Text
- View/download PDF
48. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes.
- Author
-
Foncea R, Andersson M, Ketterman A, Blakesley V, Sapag-Hagar M, Sugden PH, LeRoith D, and Lavandero S
- Subjects
- Animals, Calcium-Calmodulin-Dependent Protein Kinases drug effects, Cells, Cultured, Enzyme Activation drug effects, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Myocardium metabolism, Phosphatidylinositol 3-Kinases, Phosphorylation, Phosphotransferases (Alcohol Group Acceptor) metabolism, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-raf, Rats, Rats, Sprague-Dawley, Type C Phospholipases metabolism, Tyrosine metabolism, Heart drug effects, Insulin-Like Growth Factor I pharmacology, Mitogen-Activated Protein Kinases, Signal Transduction drug effects
- Abstract
In response to insulin-like growth factor-I (IGF-I), neonatal rat cardiac myocytes exhibit a hypertrophic response. The elucidation of the IGF-I signal transduction system in these cells remains unknown. We show here that cardiac myocytes present a single class of high affinity receptors (12,446 +/- 3,669 binding sites/cell) with a dissociation constant of 0.36 +/- 0.10 nM. Two different beta-subunits of IGF-I receptor were detected, and their autophosphorylation was followed by increases in the phosphotyrosine content of extracellular signal-regulated kinases (ERKs), insulin receptor substrate 1, phospholipase C-gamma1, and phosphatidylinositol 3-kinase. IGF-I transiently activates c-Raf in cultured neonatal cardiac myocytes, whereas A-raf is activated much less than c-Raf. Two peaks of ERK activity (ERK1 and ERK2) were resolved in cardiac myocytes treated with IGF-I by fast protein liquid chromatography, both being stimulated by IGF-I (with EC50 values for the stimulation of ERK1 and ERK2 by IGF-I of 0.10 and 0. 12 nM, respectively). Maximal activation of ERK2 (12-fold) and ERK1 (8.3-fold) activities was attained after a 5-min exposure to IGF-I. Maximal activation of p90 S6 kinase by IGF-I was achieved after 10 min, and then the activity decreased slowly. Interestingly, IGF-I stimulates incorporation of [3H]phenylalanine (1.6-fold) without any effect on [3H]thymidine incorporation. These data suggest that IGF-I activates multiple signal transduction pathways in cardiac myocytes some of which may be relevant to the hypertrophic response of the heart.
- Published
- 1997
- Full Text
- View/download PDF
49. Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes.
- Author
-
Clerk A and Sugden PH
- Subjects
- Activating Transcription Factor 2, Animals, Animals, Newborn, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Cell Nucleus metabolism, Cells, Cultured, Cytoplasm enzymology, Enzyme Activation, Heart Ventricles, JNK Mitogen-Activated Protein Kinases, Myocardium cytology, Myocardium enzymology, Phosphorylation, Rats, Rats, Sprague-Dawley, Cyclic AMP Response Element-Binding Protein metabolism, Mitogen-Activated Protein Kinases, Myocardium metabolism, Oxidative Stress, Proto-Oncogene Proteins c-jun metabolism, Transcription Factors metabolism
- Abstract
Ventricular myocytes are exposed to various pathologically important cell stresses in vivo. In vitro, extreme stresses (sorbitol-induced hyperosmotic shock in the presence or absence of okadaic acid, and anisomycin) were applied to ventricular myocytes cultured from neonatal rat hearts to induce a robust activation of the 46 and 54 kDa stress-activated protein kinases (SAPKs). These activities were increased in nuclear extracts of cells in the absence of any net import of SAPK protein. Phosphorylation of ATF2 and c-Jun was increased as shown by the appearance of reduced-mobility species on SDS/PAGE, which were sensitive to treatment with protein phosphatase 2A. Hyperosmotic shock and anisomycin had no effect on the abundance of ATF2. In contrast, cell stresses induced a greater than 10-fold increase in total c-Jun immunoreactivity detected on Western blots with antibody to c-Jun (KM-1). Cycloheximide did not inhibit this increase, which we conclude represents phosphorylation of c-Jun. This conclusion was supported by use of a c-Jun(phospho-Ser-73) antibody. Immunostaining of cells also showed increases in nuclear phospho-c-Jun in response to hyperosmotic stress. Severe stress (hyperosmotic shock+okadaic acid for 2 h) induced proteins (migrating at approx. 51 and 57 kDa) that cross-reacted strongly with KM-1 antibodies in both the nucleus and the cytosol. These may represent forms of c-Jun that had undergone further modification. These studies show that stresses induce phosphorylation of transcription factors in ventricular myocytes and we suggest that this response may be pathologically relevant.
- Published
- 1997
- Full Text
- View/download PDF
50. Activation of p21-activated protein kinase alpha (alpha PAK) by hyperosmotic shock in neonatal ventricular myocytes.
- Author
-
Clerk A and Sugden PH
- Subjects
- Animals, Animals, Newborn, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Cells, Cultured, Enzyme Activation, JNK Mitogen-Activated Protein Kinases, Myocardium cytology, Precipitin Tests, Protein Serine-Threonine Kinases chemistry, Protein Serine-Threonine Kinases immunology, Rats, Rats, Sprague-Dawley, p21-Activated Kinases, Mitogen-Activated Protein Kinases, Myocardium enzymology, Osmotic Pressure, Protein Serine-Threonine Kinases metabolism
- Abstract
The p21-activated protein kinases (PAKs) may participate in signalling from Cdc42/Rac1 to the stress-regulated MAPKs (SAPKs/JNKs and p38-/HOG-1-related-MAPKs). We characterized the expression and regulation of alpha PAK in cultured ventricular myocytes. alpha PAK was specifically immunoprecipitated from myocyte extracts. High basal alpha PAK activity was detected in unstimulated myocytes. Its activity was increased rapidly (<30 s) by hyperosmotic shock in the presence of okadaic acid, and was maximal by 3 min (187 +/- 7% relative to unstimulated cells). Endothelin-1 and interleukin-1beta, which also activate SAPKs/JNKs, did not increase alpha PAK activity and presumably act through different PAK isoforms or other mechanisms.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.